 |
 |

Dapsone-Induced Peripheral NeuropathyCase Report and Review
Thomas P. Waldinger, MD;
Ronald J. Siegle, MD;
Wendell Weber, PhD, MD;
John J. Voorhees, MD
Arch Dermatol. 1984;120(3):356-359.
Abstract
 |  |
A severe motor and a minor sensory neuropathy developed in a man being treated with dapsone (4,4'-diaminodiphenylsulfone) for dermatitis herpetiformis. He had received dapsone for 16 years before any signs of neurotoxicity became evident. Electrodiagnostic and clinical features were consistent with an axonal neuropathy. Clinical characteristics of dapsone-induced neuropathy include a motor neuropathy affecting the extremities, usual onset within five years after the initiation of dapsone therapy, dapsone dosage usually equal to or greater than 300 mg/day, and, almost always, complete recovery from the neuropathy after dapsone-dose reduction or withdrawal. The patient was found to be a slow acetylator of sulfamethazine, and therefore is a slow acetylator of dapsone. An HLA typing was done on the patient. New cases of dapsone-induced neuropathy should be HLA typed and have acetylation profiles in an attempt to identify future high-risk patients. This case is noteworthy for the length of time of dapsone usage (16 years) and the low daily dosage of dapsone (100 mg) taken prior to the development of neuropathy.
(Arch Dermatol 1984;120:356-359)
Author Affiliations
From the Departments of Dermatology (Drs Waldinger, Siegle, and Voorhees) and Pharmacology (Dr Weber), University of Michigan Medical Center, Ann Arbor.
Footnotes
Accepted for publication July 5, 1983.
Reprint requests to Department of Dermatology, University of Michigan Medical School, C2071 Outpatient Building, Ann Arbor, MI 48109 (Dr Waldinger).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Lessons to be learned: a case study approach: Prolonged methaemoglobinaemia due to inadvertent dapsone poisoning; treatment with methylene blue and exchange transfusion
Southgate and Masterson
The Journal of the Royal Society for the Promotion of Health 1999;119:52-55.
ABSTRACT
|